Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$320,396
in 6 filings

Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 52 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-06 Kalowski Lee CFO and President Sale −1,301 $8.32 $11K 137,170
2026-08-25 Kalowski Lee CFO and President Sale −3,972 $16.56 $66K 138,471
2026-07-16 Kalowski Lee CFO and President Grant or award +53,250 142,443
2026-02-25 Kalowski Lee CFO and President Sale −3,995 $4.51 $18K 35,943
2026-02-24 Kalowski Lee CFO and President Grant or award +53,250 89,193
2025-12-02 Kalowski Lee CFO and President Sale −9,072 $3.46 $31K 39,938
2025-08-26 Kalowski Lee CFO and President Sale −4,240 $1.80 $8K 49,010
2025-02-24 Kalowski Lee CFO and President Grant or award +53,250 53,250
2025-02-24 Kalowski Lee CFO and President Returned to the company · Stock Option (Right to Buy) −16,901 0
2025-02-24 Kalowski Lee CFO and President Grant or award · Stock Option (Right to Buy) +16,901 16,901
2025-02-24 Kalowski Lee CFO and President Returned to the company · Stock Option (Right to Buy) −161,323 0
2025-02-24 Kalowski Lee CFO and President Grant or award · Stock Option (Right to Buy) +161,323 161,323
2024-03-25 Kalowski Lee CFO and President Grant or award · Stock Option (Right to Buy) +161,323 161,323

Page 1 of 1 · 13 trades